Literature DB >> 12966191

Stone composition, metabolic profile and the presence of the gut-inhabiting bacterium Oxalobacter formigenes as risk factors for renal stone formation.

R D Mittal1, R Kumar, B Mittal, R Prasad, M Bhandari.   

Abstract

OBJECTIVE: To examine stone composition, metabolic evaluation and colonization of Oxalobacter formigenes as risk factors for renal stone formation. SUBJECTS AND METHODS: Eighty patients with renal stones and 70 healthy controls were enrolled in the study. Of the 80 patients, 48 were first-time stone formers (FSF) and 32 were 'recurrent' stone formers (RSF), recurrent indicating 2 or more episodes of stone formation. Stone analysis by X-ray crystallography, 24-hour urine metabolic profile and detection of O. formigenes-specific DNA by PCR were performed for each patient. Detection of O. formigenes was also performed on 45 and urinary metabolic profile on an additional 25 controls.
RESULTS: Calcium oxalate monohydrate was the major component of stones, hyperoxaluria and hypocitraturia were the most common urinary abnormalities in the 80 patients, 46% of RSF patients had hypercalciuria. Urinary abnormalities were far less frequent in the controls, with the exception of hypocitraturia (40%). Of the urinary metabolites, only calcium levels were significantly different (p < 0.05) between FSF (6.50 +/- 4.08 mmol/24 h) and RSF (8.21 +/- 5.26 mmol/24 h) patients. Colonization of O. formigenes was higher in controls (62.2%) than in FSF (33.3%) or RSF (28%) patients, it was least in patients with more than 4 episodes (7%) of stone formation.
CONCLUSION: The findings indicate that lack of colonization of O. formigenes may be an important risk factor for recurrence of stone formation (calcium oxalate monohydrate). Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12966191     DOI: 10.1159/000072285

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  15 in total

1.  Inhibition of urinary stone disease by a multi-species bacterial network ensures healthy oxalate homeostasis.

Authors:  Aaron W Miller; David Choy; Kristina L Penniston; Dirk Lange
Journal:  Kidney Int       Date:  2019-02-28       Impact factor: 10.612

Review 2.  Intestinal transport of an obdurate anion: oxalate.

Authors:  Marguerite Hatch; Robert W Freel
Journal:  Urol Res       Date:  2004-11-25

Review 3.  The roles and mechanisms of intestinal oxalate transport in oxalate homeostasis.

Authors:  Marguerite Hatch; Robert W Freel
Journal:  Semin Nephrol       Date:  2008-03       Impact factor: 5.299

4.  Oral antibiotic treatment of Helicobacter pylori leads to persistently reduced intestinal colonization rates with Oxalobacter formigenes.

Authors:  Viktoria Kharlamb; Jennifer Schelker; Fritz Francois; Juquan Jiang; Ross P Holmes; David S Goldfarb
Journal:  J Endourol       Date:  2011-10-21       Impact factor: 2.942

5.  Quantitative analysis of colonization with real-time PCR to identify the role of Oxalobacter formigenes in calcium oxalate urolithiasis.

Authors:  Ertan Batislam; Erdal Yilmaz; Ercan Yuvanc; Ozgul Kisa; Ucler Kisa
Journal:  Urol Res       Date:  2012-01-04

6.  Gut microbiota and oxalate homeostasis.

Authors:  Marguerite Hatch
Journal:  Ann Transl Med       Date:  2017-01

7.  Induction of enteric oxalate secretion by Oxalobacter formigenes in mice does not require the presence of either apical oxalate transport proteins Slc26A3 or Slc26A6.

Authors:  Marguerite Hatch
Journal:  Urolithiasis       Date:  2019-06-14       Impact factor: 3.436

Review 8.  The role of the microbiome in kidney stone formation.

Authors:  Mansi Mehta; David S Goldfarb; Lama Nazzal
Journal:  Int J Surg       Date:  2016-11-12       Impact factor: 6.071

Review 9.  Updates in the Metabolic Management of Calcium Stones.

Authors:  Kristina L Penniston; Stephen Y Nakada
Journal:  Curr Urol Rep       Date:  2018-04-16       Impact factor: 3.092

Review 10.  The management of patients with enteric hyperoxaluria.

Authors:  John R Asplin
Journal:  Urolithiasis       Date:  2015-12-08       Impact factor: 3.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.